Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $2.0 million.

  • Connect Biopharma Holdings' Accounts Payables changed N/A to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $342000.0 for FY2024, which is 8451.79% down from last year.
  • As of Q3 2025, Connect Biopharma Holdings' Accounts Payables stood at $2.0 million.
  • In the past 5 years, Connect Biopharma Holdings' Accounts Payables registered a high of $11.5 million during Q2 2023, and its lowest value of $342000.0 during Q4 2024.
  • Moreover, its 3-year median value for Accounts Payables was $2.2 million (2023), whereas its average is $3.6 million.
  • Examining YoY changes over the last 5 years, Connect Biopharma Holdings' Accounts Payables showed a top increase of 5051.22% in 2024 and a maximum decrease of 8451.79% in 2024.
  • Over the past 3 years, Connect Biopharma Holdings' Accounts Payables (Quarter) stood at $2.2 million in 2023, then crashed by 84.52% to $342000.0 in 2024, then skyrocketed by 483.04% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.3 million for Q2 2025, and $817000.0 during Q1 2025.